{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T21:38:02Z","timestamp":1706132282295},"reference-count":97,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice &amp; Research Clinical Obstetrics &amp; Gynaecology"],"published-print":{"date-parts":[[2005,8]]},"DOI":"10.1016\/j.bpobgyn.2005.02.006","type":"journal-article","created":{"date-parts":[[2005,4,13]],"date-time":"2005-04-13T18:20:31Z","timestamp":1113416431000},"page":"531-544","source":"Crossref","is-referenced-by-count":8,"title":["Strategies for the prevention of cervical cancer by human papillomavirus vaccination"],"prefix":"10.1016","volume":"19","author":[{"given":"A.-L.","family":"Williamson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-A.","family":"Passmore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.P.","family":"Rybicki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpobgyn.2005.02.006_bib1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.virol.2004.03.033","article-title":"Classification of papillomaviruses","volume":"324","author":"de Villiers","year":"2004","journal-title":"Virology"},{"key":"10.1016\/j.bpobgyn.2005.02.006_bib2","doi-asserted-by":"crossref","first-page":"4818","DOI":"10.1128\/JVI.77.8.4818-4826.2003","article-title":"Interactions between papillomavirus L1 and L2 capsid proteins","volume":"77","author":"Finnen","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.bpobgyn.2005.02.006_bib3","series-title":"Fields Virology","first-page":"2197","article-title":"Papillomavirinae: the viruses and their replication","author":"Howley","year":"2001"},{"key":"10.1016\/j.bpobgyn.2005.02.006_bib4","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1056\/NEJMoa021641","article-title":"Epidemiologic classification of human papillomavirus types associated with cervical cancer","volume":"348","author":"Munoz","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bpobgyn.2005.02.006_bib5","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1093\/infdis\/171.4.1026","article-title":"Human papillomavirus infection is transient in young women: a population-based cohort study","volume":"171","author":"Evander","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1016\/j.bpobgyn.2005.02.006_bib6","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1093\/jnci\/92.6.464","article-title":"Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica","volume":"92","author":"Herrero","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.bpobgyn.2005.02.006_bib7","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1099\/0022-1317-80-2-409","article-title":"Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. II. Systemic but not local IgA responses correlate with clearance of HPV-16","volume":"80","author":"Bontkes","year":"1999","journal-title":"J Gen Virol"},{"key":"10.1016\/j.bpobgyn.2005.02.006_bib8","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1128\/CDLI.6.5.751-755.1999","article-title":"Th1 cytokine patterns in cervical human papillomavirus infection","volume":"6","author":"Scott","year":"1999","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.bpobgyn.2005.02.006_bib9","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1128\/CDLI.8.2.209-220.2001","article-title":"Cell-mediated immune response to human papillomavirus infection","volume":"8","author":"Scott","year":"2001","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.bpobgyn.2005.02.006_bib10","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0165-0378(01)00113-9","article-title":"Immunobiology of papillomavirus infections","volume":"52","author":"Stanley","year":"2001","journal-title":"J Reprod Immunol"},{"key":"10.1016\/j.bpobgyn.2005.02.006_bib11","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nri1260","article-title":"Prevention of cervical cancer through papillomavirus vaccination","volume":"4","author":"Frazer","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.bpobgyn.2005.02.006_bib12","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nrc700","article-title":"Immune evasion in human papillomavirus-associated cervical cancer","volume":"2","author":"Tindle","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.bpobgyn.2005.02.006_bib13","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1600-065X.1999.tb01288.x","article-title":"Potential strategies utilised by papillomavirus to evade host immunity","volume":"168","author":"Frazer","year":"1999","journal-title":"Immunol Rev"},{"key":"10.1016\/j.bpobgyn.2005.02.006_bib14","doi-asserted-by":"crossref","first-page":"4972","DOI":"10.1128\/JVI.73.6.4972-4982.1999","article-title":"Papillomavirus capsid protein expression level depends on the match between codon usage and tRNA availability","volume":"73","author":"Zhou","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/j.bpobgyn.2005.02.006_bib15","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1086\/315498","article-title":"Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection","volume":"181","author":"Carter","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.bpobgyn.2005.02.006_bib16","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1093\/jnci\/86.7.494","article-title":"A virus-like particle enzyme-linked immunosorbent assay detects serum antibodies in a majority of women infected with human papillomavirus type 16","volume":"86","author":"Kirnbauer","year":"1994","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.bpobgyn.2005.02.006_bib17","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1128\/JCM.33.5.1380-1382.1995","article-title":"Detection of antibodies against human papillomavirus (HPV) type 16 virions by enzyme-linked immunosorbent assay using recombinant HPV 16 L1 capsids produced by recombinant baculovirus","volume":"33","author":"Le Cann","year":"1995","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.bpobgyn.2005.02.006_bib18","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1093\/infdis\/174.5.927","article-title":"The natural history of human papillomavirus type 16 capsid antibodies among a cohort of university women","volume":"174","author":"Carter","year":"1996","journal-title":"J Infect Dis"},{"key":"10.1016\/j.bpobgyn.2005.02.006_bib19","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1093\/jnci\/81.22.1698","article-title":"Antibodies against the human papillomavirus type 16 early proteins in human sera: correlation of anti-E7 reactivity with cervical cancer","volume":"81","author":"Jochmus-Kudielka","year":"1989","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.bpobgyn.2005.02.006_bib20","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1086\/315364","article-title":"Detection of cervical antibodies to human papillomavirus type 16 (HPV-16) capsid antigens in relation to detection of HPV-16 DNA and cervical lesions","volume":"181","author":"Hagensee","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.bpobgyn.2005.02.006_bib21","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.1128\/JCM.34.12.3056-3062.1996","article-title":"Cervical mucus antibodies against human papillomavirus type 16, 18, and 33 capsids in relation to presence of viral DNA","volume":"34","author":"Wang","year":"1996","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.bpobgyn.2005.02.006_bib22","series-title":"Papillomavirus Reviews: Current Research on Papillomaviruses","first-page":"271","article-title":"HPV in the immunosuppressed","author":"Benton","year":"1996"},{"key":"10.1016\/j.bpobgyn.2005.02.006_bib23","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/infdis\/172.1.11","article-title":"Use of human papillomavirus type 6 capsids to detect antibodies in people with genital warts","volume":"172","author":"Carter","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1016\/j.bpobgyn.2005.02.006_bib24","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1128\/JCM.33.8.2058-2063.1995","article-title":"Human papillomavirus (HPV) type distribution and serological response to HPV type 6 virus-like particles in patients with genital warts","volume":"33","author":"Greer","year":"1995","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.bpobgyn.2005.02.006_bib25","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1093\/infdis\/172.2.395","article-title":"Serum IgG, IgM, and IgA reactivity to human papillomavirus types 11 and 6 virus-like particles in different gynecologic patient groups","volume":"172","author":"Heim","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1016\/j.bpobgyn.2005.02.006_bib26","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1093\/ajcp\/102.6.768","article-title":"Immunological events in regressing genital warts","volume":"102","author":"Coleman","year":"1994","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.bpobgyn.2005.02.006_bib27","doi-asserted-by":"crossref","first-page":"52","DOI":"10.2340\/00015555735254","article-title":"Epidermodysplasia verruciformis accompanied by familial large granular lymphocytosis and a decrease in T lymphocytes","volume":"73","author":"Aoyama","year":"1993","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.bpobgyn.2005.02.006_bib28","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1006\/viro.2000.0789","article-title":"Regression of canine oral papillomas is associated with infiltration of CD4+ and CD8+ lymphocytes","volume":"283","author":"Nicholls","year":"2001","journal-title":"Virology"},{"key":"10.1016\/j.bpobgyn.2005.02.006_bib29","first-page":"7324","article-title":"Differential response of nontumorigenic and tumorigenic human papillomavirus type 16-positive epithelial cells to transforming growth factor beta 1","volume":"50","author":"Braun","year":"1990","journal-title":"Cancer Res"},{"key":"10.1016\/j.bpobgyn.2005.02.006_bib30","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/1523-1747.ep12606028","article-title":"Association of tumor necrosis factor-alpha gene expression and apoptotic cell death with regression of Shope papillomas","volume":"104","author":"Hagari","year":"1995","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.bpobgyn.2005.02.006_bib31","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1073\/pnas.92.7.2840","article-title":"Interleukin 1 alpha and tumor necrosis factor alpha stimulate autocrine amphiregulin expression and proliferation of human papillomavirus-immortalized and carcinoma-derived cervical epithelial cells","volume":"92","author":"Woodworth","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bpobgyn.2005.02.006_bib32","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0738-081X(97)00049-7","article-title":"Cellular immunity in cutaneous and genital HPV infections","volume":"15","author":"Malejczyk","year":"1997","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.bpobgyn.2005.02.006_bib33","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1006\/cyto.2001.0909","article-title":"Cytokines in cervicovaginal washing fluid from patients with cervical neoplasia","volume":"14","author":"Tjiong","year":"2001","journal-title":"Cytokine"},{"key":"10.1016\/j.bpobgyn.2005.02.006_bib34","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/jnci\/89.3.245","article-title":"Cytokine production patterns in cervical intraepithelial neoplasia: association with human papillomavirus infection","volume":"89","author":"Clerici","year":"1997","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.bpobgyn.2005.02.006_bib35","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/path.929","article-title":"Quantitative analysis of IL-10 and IFN-gamma mRNA levels in normal cervix and human papillomavirus type 16 associated cervical precancer","volume":"195","author":"El-Sherif","year":"2001","journal-title":"J Pathol"},{"key":"10.1016\/j.bpobgyn.2005.02.006_bib36","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1046\/j.1365-2249.1999.00826.x","article-title":"The antigen-presenting environment in normal and human papillomavirus (HPV)-related premalignant cervical epithelium","volume":"116","author":"Mota","year":"1999","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.bpobgyn.2005.02.006_bib37","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0166-3542(02)00070-0","article-title":"Interleukin-10 induces transcription of the early promoter of human papillomavirus type 16 (HPV16) through the 5\u2032-segment of the upstream regulatory region (URR)","volume":"55","author":"Arany","year":"2002","journal-title":"Antiviral Res"},{"key":"10.1016\/j.bpobgyn.2005.02.006_bib38","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0959-8049(05)80047-4","article-title":"Definition of immunogenic determinants of the human papillomavirus type 16 nucleoprotein E7","volume":"28","author":"Altmann","year":"1992","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.bpobgyn.2005.02.006_bib39","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1099\/0022-1317-77-4-593","article-title":"Proliferative T cell responses to human papillomavirus type 16 L1 peptides in patients with cervical dysplasia","volume":"77","author":"Shepherd","year":"1996","journal-title":"J Gen Virol"},{"key":"10.1016\/j.bpobgyn.2005.02.006_bib40","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1006\/bbrc.1995.1535","article-title":"Human T helper cell epitopes overlap B cell and putative cytotoxic T cell epitopes in the E2 protein of human papillomavirus type 16","volume":"209","author":"Lehtinen","year":"1995","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bpobgyn.2005.02.006_bib41","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1128\/CDLI.3.2.205-210.1996","article-title":"T-cell proliferative response to human papillomavirus type 16 peptides: relationship to cervical intraepithelial neoplasia","volume":"3","author":"Nakagawa","year":"1996","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.bpobgyn.2005.02.006_bib42","doi-asserted-by":"crossref","first-page":"6427","DOI":"10.1128\/JVI.71.9.6427-6432.1997","article-title":"Isolation and characterization of human papillomavirus type 6-specific T cells infiltrating genital warts","volume":"71","author":"Hong","year":"1997","journal-title":"J Virol"},{"key":"10.1016\/j.bpobgyn.2005.02.006_bib43","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/1097-0215(20001101)88:3<489::AID-IJC25>3.0.CO;2-Q","article-title":"The spectrum of HIV-1 related cancers in South Africa","volume":"88","author":"Sitas","year":"2000","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bpobgyn.2005.02.006_bib44","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1006\/gyno.2000.5775","article-title":"Human immunodeficiency virus infection and invasive cervical cancer in South Africa","volume":"77","author":"Lomalisa","year":"2000","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2005.02.006_bib45","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1046\/j.1525-1438.2001.01022.x","article-title":"Invasive cervical cancer and human immunodeficiency virus (HIV) infection: a South African perspective","volume":"11","author":"Moodley","year":"2001","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.bpobgyn.2005.02.006_bib46","first-page":"97","article-title":"Is HIV infection a cofactor for cervical squamous cell neoplasia?","volume":"8","author":"Mandelblatt","year":"1999","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.bpobgyn.2005.02.006_bib47","first-page":"431","article-title":"Human papillomavirus and HIV coinfection and the risk of neoplasias of the lower genital tract: a review of recent developments","volume":"169","author":"Ferenczy","year":"2003","journal-title":"CMAJ"},{"key":"10.1016\/j.bpobgyn.2005.02.006_bib48","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/infdis\/172.1.235","article-title":"Incidence of venereal warts in human immunodeficiency virus-infected and uninfected women","volume":"172","author":"Chirgwin","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1016\/j.bpobgyn.2005.02.006_bib49","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1086\/315815","article-title":"The impact of human immunodeficiency virus type 1 status on human papillomavirus (HPV) prevalence and HPV antibodies in serum and cervical secretions","volume":"182","author":"Marais","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.bpobgyn.2005.02.006_bib50","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/jmv.20115","article-title":"Human papillomavirus in a rural community in Zimbabwe: the impact of HIV co-infection on HPV genotype distribution","volume":"73","author":"Baay","year":"2004","journal-title":"J Med Virol"},{"key":"10.1016\/j.bpobgyn.2005.02.006_bib51","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ygyno.2003.10.004","article-title":"Presence of multiple human papillomavirus types in cervical samples from HIV-infected women","volume":"92","author":"Levi","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2005.02.006_bib52","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/jmv.20244","article-title":"Prevalence of human papillomavirus genotypes in women from three clinical settings","volume":"75","author":"Chaturvedi","year":"2005","journal-title":"J Med Virol"},{"key":"10.1016\/j.bpobgyn.2005.02.006_bib53","doi-asserted-by":"crossref","first-page":"11553","DOI":"10.1073\/pnas.92.25.11553","article-title":"Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas","volume":"92","author":"Suzich","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bpobgyn.2005.02.006_bib54","doi-asserted-by":"crossref","first-page":"3959","DOI":"10.1128\/JVI.69.6.3959-3963.1995","article-title":"Immunization with viruslike particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection","volume":"69","author":"Breitburd","year":"1995","journal-title":"J Virol"},{"key":"10.1016\/j.bpobgyn.2005.02.006_bib55","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1099\/0022-1317-80-9-2471","article-title":"A recombinant human papillomavirus (HPV) type 16 L1-vaccinia virus murine challenge model demonstrates cell-mediated immunity against HPV virus-like particles","volume":"80","author":"Marais","year":"1999","journal-title":"J Gen Virol"},{"key":"10.1016\/j.bpobgyn.2005.02.006_bib56","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1006\/viro.1998.9372","article-title":"L1-specific protection from tumor challenge elicited by HPV16 virus-like particles","volume":"250","author":"De Bruijn","year":"1998","journal-title":"Virology"},{"key":"10.1016\/j.bpobgyn.2005.02.006_bib57","doi-asserted-by":"crossref","first-page":"12180","DOI":"10.1073\/pnas.89.24.12180","article-title":"Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic","volume":"89","author":"Kirnbauer","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bpobgyn.2005.02.006_bib58","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1006\/jmbi.2000.4464","article-title":"Papillomavirus capsid protein expression in Escherichia coli: purification and assembly of HPV11 and HPV16 L1","volume":"307","author":"Chen","year":"2001","journal-title":"J Mol Biol"},{"key":"10.1016\/j.bpobgyn.2005.02.006_bib59","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1099\/0022-1317-75-9-2271","article-title":"Assembled baculovirus-expressed human papillomavirus type 11 L1 capsid protein virus-like particles are recognized by neutralizing monoclonal antibodies and induce high titres of neutralizing antibodies","volume":"75","author":"Christensen","year":"1994","journal-title":"J Gen Virol"},{"key":"10.1016\/j.bpobgyn.2005.02.006_bib60","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1128\/JVI.71.4.2988-2995.1997","article-title":"Expression of the human papillomavirus type 11 L1 capsid protein in Escherichia coli: characterization of protein domains involved in DNA binding and capsid assembly","volume":"71","author":"Li","year":"1997","journal-title":"J Virol"},{"key":"10.1016\/j.bpobgyn.2005.02.006_bib61","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.1128\/IAI.65.8.3328-3336.1997","article-title":"Human papillomavirus type 16 virus-like particles expressed in attenuated Salmonella typhimurium elicit mucosal and systemic neutralizing antibodies in mice","volume":"65","author":"Nardelli-Haefliger","year":"1997","journal-title":"Infect Immun"},{"key":"10.1016\/j.bpobgyn.2005.02.006_bib62","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1128\/JVI.67.4.1936-1944.1993","article-title":"Expression of human papillomavirus type 11 L1 protein in insect cells: in vivo and in vitro assembly of viruslike particles","volume":"67","author":"Rose","year":"1993","journal-title":"J Virol"},{"key":"10.1016\/j.bpobgyn.2005.02.006_bib63","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1099\/0022-1317-75-8-2075","article-title":"Human papillomavirus (HPV) type 11 recombinant virus-like particles induce the formation of neutralizing antibodies and detect HPV-specific antibodies in human sera","volume":"75","author":"Rose","year":"1994","journal-title":"J Gen Virol"},{"key":"10.1016\/j.bpobgyn.2005.02.006_bib64","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S0042-6822(95)80027-1","article-title":"Synthesis and assembly of virus-like particles of human papillomaviruses type 6 and type 16 in fission yeast Schizosaccharomyces pombe","volume":"206","author":"Sasagawa","year":"1995","journal-title":"Virology"},{"key":"10.1016\/j.bpobgyn.2005.02.006_bib65","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1007\/s00705-003-0119-4","article-title":"Expression of human papillomavirus type 16 major capsid protein in transgenic Nicotiana tabacum cv. Xanthi","volume":"148","author":"Varsani","year":"2003","journal-title":"Arch Virol"},{"key":"10.1016\/j.bpobgyn.2005.02.006_bib66","doi-asserted-by":"crossref","first-page":"8702","DOI":"10.1128\/JVI.77.16.8702-8711.2003","article-title":"Oral immunogenicity of human papillomavirus-like particles expressed in potato","volume":"77","author":"Warzecha","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.bpobgyn.2005.02.006_bib67","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/0042-6822(92)90582-A","article-title":"Definition of linear antigenic regions of the HPV16 L1 capsid protein using synthetic virion-like particles","volume":"189","author":"Zhou","year":"1992","journal-title":"Virology"},{"key":"10.1016\/j.bpobgyn.2005.02.006_bib68","doi-asserted-by":"crossref","first-page":"6151","DOI":"10.1128\/JVI.72.7.6151-6154.1998","article-title":"Human papillomavirus type 11 recombinant L1 capsomeres induce virus-neutralizing antibodies","volume":"72","author":"Rose","year":"1998","journal-title":"J Virol"},{"key":"10.1016\/j.bpobgyn.2005.02.006_bib69","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1179\/095741903225003235","article-title":"Papillomavirus\/cell-interactions initiating the infectious entry pathway","volume":"14","author":"Selinka","year":"2003","journal-title":"Papillomavirus Rep"},{"key":"10.1016\/j.bpobgyn.2005.02.006_bib70","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1517\/14712598.1.4.571","article-title":"Papillomavirus-like particle based vaccines: cervical cancer and beyond","volume":"1","author":"Schiller","year":"2001","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.bpobgyn.2005.02.006_bib71","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1056\/NEJMoa020586","article-title":"A controlled trial of a human papillomavirus type 16 vaccine","volume":"347","author":"Koutsky","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bpobgyn.2005.02.006_bib72","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/S0140-6736(04)17398-4","article-title":"Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial","volume":"364","author":"Harper","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.bpobgyn.2005.02.006_bib73","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.1128\/JVI.77.8.4635-4645.2003","article-title":"Human papillomavirus type 16 L1 capsomeres induce L1-specific cytotoxic T lymphocytes and tumor regression in C57BL\/6 mice","volume":"77","author":"Ohlschlager","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.bpobgyn.2005.02.006_bib74","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/S0264-410X(00)00370-4","article-title":"Immunological analyses of human papillomavirus capsids","volume":"19","author":"Giroglou","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.bpobgyn.2005.02.006_bib75","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3201\/eid0901.020168","article-title":"Cost-effectiveness of a potential vaccine for human papillomavirus","volume":"9","author":"Sanders","year":"2003","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.bpobgyn.2005.02.006_bib76","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.3201\/eid1011.040222","article-title":"Evaluating human papillomavirus vaccination programs","volume":"10","author":"Taira","year":"2004","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.bpobgyn.2005.02.006_bib77","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.1128\/IAI.65.8.3328-3336.1997","article-title":"Human papillomavirus type 16 virus-like particles expressed in attenuated Salmonella typhimurium elicit mucosal and systemic neutralizing antibodies in mice","volume":"65","author":"Nardelli-Haefliger","year":"1997","journal-title":"Infect Immun"},{"key":"10.1016\/j.bpobgyn.2005.02.006_bib78","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1016\/S0264-410X(99)00550-2","article-title":"Immune responses induced by BCG recombinant for human papillomavirus L1 and E7 proteins","volume":"18","author":"Jabbar","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.bpobgyn.2005.02.006_bib79","unstructured":"Goran VA, Christensen ND, Jacobs WR, Williamson A.-L. Recombinant BCG expressing cottontail rabbit papillomavirus (CRPV) L1 gene provides partial protection in rabbits challenged with CRPV virus. 22nd International Papillomavirus Conference, Mexico, 2004."},{"key":"10.1016\/j.bpobgyn.2005.02.006_bib80","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/ijc.10759","article-title":"Oral vaccination with recombinant Listeria monocytogenes expressing human papillomavirus type 16 E7 can cause tumor growth in mice to regress","volume":"102","author":"Lin","year":"2002","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bpobgyn.2005.02.006_bib81","doi-asserted-by":"crossref","first-page":"12901","DOI":"10.1128\/JVI.78.23.12901-12909.2004","article-title":"Improved efficiency of a Salmonella-based vaccine against human papillomavirus type 16 virus-like particles achieved by using a codon-optimized version of L1","volume":"78","author":"Baud","year":"2004","journal-title":"J Virol"},{"issue":"supplement","key":"10.1016\/j.bpobgyn.2005.02.006_bib82","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/nm0598supp-502","article-title":"Pharmaceutical foodstuffs\u2014oral immunization with transgenic plants","volume":"4","author":"Arntzen","year":"1998","journal-title":"Nat Med"},{"key":"10.1016\/j.bpobgyn.2005.02.006_bib83","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1016\/S0264-410X(98)00484-8","article-title":"Oral vaccination of mice with human papillomavirus virus-like particles induces systemic virus-neutralizing antibodies","volume":"17","author":"Rose","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.bpobgyn.2005.02.006_bib84","doi-asserted-by":"crossref","first-page":"4752","DOI":"10.1128\/JVI.75.10.4752-4760.2001","article-title":"Human papillomavirus virus-like particles are efficient oral immunogens when coadministered with Escherichia coli heat-labile enterotoxin mutant R192G or CpG DNA","volume":"75","author":"Gerber","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.bpobgyn.2005.02.006_bib85","doi-asserted-by":"crossref","first-page":"9211","DOI":"10.1128\/JVI.77.17.9211-9220.2003","article-title":"Production of human papillomavirus type 16 virus-like particles in transgenic plants","volume":"77","author":"Biemelt","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.bpobgyn.2005.02.006_bib86","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1007\/s00705-003-0119-4","article-title":"Expression of human papillomavirus type 16 major capsid protein in transgenic Nicotiana tabacum cv. Xanthi","volume":"148","author":"Varsani","year":"2003","journal-title":"Arch Virol"},{"key":"10.1016\/j.bpobgyn.2005.02.006_bib87","doi-asserted-by":"crossref","first-page":"8702","DOI":"10.1128\/JVI.77.16.8702-8711.2003","article-title":"Oral immunogenicity of human papillomavirus-like particles expressed in potato","volume":"77","author":"Warzecha","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.bpobgyn.2005.02.006_bib88","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1016\/j.vaccine.2004.01.049","article-title":"Effect of TA-CIN (HPV 16 L2E6E7) booster immunisation in vulval intraepithelial neoplasia patients previously vaccinated with TA-HPV (vaccinia virus encoding HPV 16\/18 E6E7)","volume":"22","author":"Davidson","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.bpobgyn.2005.02.006_bib89","first-page":"5205","article-title":"Vaccinia-expressed human papillomavirus 16 and 18 e6 and e7 as a therapeutic vaccination for vulval and vaginal intraepithelial neoplasia","volume":"9","author":"Baldwin","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bpobgyn.2005.02.006_bib90","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1089\/10430340460745757","article-title":"Therapeutic vaccination with MVA E2 can eliminate precancerous lesions (CIN 1, CIN 2, and CIN 3) associated with infection by oncogenic human papillomavirus","volume":"15","author":"Corona-Gutierrez","year":"2004","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.bpobgyn.2005.02.006_bib91","first-page":"472","article-title":"Frequent detection of human papillomavirus 16 E2-specific T-helper immunity in healthy subjects","volume":"62","author":"de Jong","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.bpobgyn.2005.02.006_bib92","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1099\/0022-1317-75-9-2445","article-title":"Serological differentiation of human papillomavirus types 11, 16 and 18 using recombinant virus-like particles","volume":"75","author":"Rose","year":"1994","journal-title":"J Gen Virol"},{"key":"10.1016\/j.bpobgyn.2005.02.006_bib93","doi-asserted-by":"crossref","first-page":"8386","DOI":"10.1128\/JVI.77.15.8386-8393.2003","article-title":"Chimeric HPV-16 L1 particles presenting the common neutralising epitope for the L2 minor capsid protein of HPV types 6 and 16","volume":"77","author":"Varsani","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.bpobgyn.2005.02.006_bib94","doi-asserted-by":"crossref","first-page":"4256","DOI":"10.1016\/S0264-410X(03)00454-7","article-title":"Safety and immunogenicity of a peptide containing the cross-neutralization epitope of HPV16 L2 administered nasally in healthy volunteers","volume":"21","author":"Kawana","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.bpobgyn.2005.02.006_bib95","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1086\/320190","article-title":"A phase 1 study of a recombinant viruslike particle vaccine against human papillomavirus type 11 in healthy adult volunteers","volume":"183","author":"Evans","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1016\/j.bpobgyn.2005.02.006_bib96","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/S0264-410X(99)00351-5","article-title":"HPV6b virus like particles are potent immunogens without adjuvant in man","volume":"18","author":"Zhang","year":"2000","journal-title":"Vaccine"},{"issue":"15","key":"10.1016\/j.bpobgyn.2005.02.006_bib97","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1093\/jnci\/djg018","article-title":"Specific antibody levels at the cervix during the menstrual cycle of women vaccinated with human papillomavirus 16 virus-like particles","volume":"95","author":"Nardelli-Haefliger","year":"2003","journal-title":"J Natl Cancer Inst"}],"container-title":["Best Practice &amp; Research Clinical Obstetrics &amp; Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693405000453?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693405000453?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T20:45:43Z","timestamp":1706129143000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521693405000453"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8]]},"references-count":97,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["S1521693405000453"],"URL":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2005.02.006","relation":{},"ISSN":["1521-6934"],"issn-type":[{"value":"1521-6934","type":"print"}],"subject":[],"published":{"date-parts":[[2005,8]]}}}